Naltrexone and Buprenorphine Market

The Naltrexone and Buprenorphine market consists of medications used to treat opioid and alcohol use disorders. The primary customers are healthcare systems, including hospitals, treatment centers, and primary care providers who prescribe these drugs. Key growth drivers include a strategic shift towards long-term recovery planning, the expansion of treatment into primary care settings, and strong government support for increasing patient access to these medications.